CME favorite in New York to cover care of tricuspid valve disease too
Findings reveal lower survival, fewer interventions relative to primary MR
Our experts recap key changes and developments
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
FDA makes MitraClip available to more patients with mitral regurgitation
Practical insights from two world experts in medical and surgical management
The pulse of progress in percutaneous mitral, tricuspid and pulmonary valve procedures
Nov. 30-Dec. 1 course takes a highly case-based approach
Profile of six ongoing studies aiming to overcome anatomic hurdles
World experts offer a deep dive into a highly prevalent disease
